Dr. Bullock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
# Shapiro
Boston, MA 02215Phone+1 617-667-7000
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
Washington University in St. Louis School of MedicineClass of 2004
Certifications & Licensure
MA State Medical License 2006 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors Start of enrollment: 2012 Oct 01
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
- Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer Start of enrollment: 2020 May 18
- Join now to see all
Publications & Presentations
PubMed
- 863 citationsPembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, pha...Kohei Shitara, Mustafa Ozguroglu, Yung-Jue Bang, Maria Di Bartolomeo, Mario Mandalà
Lancet. 2018-07-14 - 140 citationsAssociation of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal AdenocarcinomaZhi Rong Qian, Douglas A. Rubinson, Jonathan A. Nowak, Vicente Morales-Oyarvide, Richard F. Dunne
JAMA Oncology. 2017-11-02 - 41 citationsOrganoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer.Joseph E. Grossman, Lakshmi Muthuswamy, Ling Huang, Dipikaa Akshinthala, Sofia Perea
Clinical Cancer Research. 2021-11-17
Journal Articles
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
Press Mentions
Researchers Discuss Future of Cancer Therapies at 15th Annual Cancer SymposiumNovember 11th, 2022- Researchers Discuss the Future of Cancer Therapies at 15th Annual Cancer SymposiumNovember 10th, 2022
- Folfox+Irinotecan+Chemort in Esophageal CancerDecember 7th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
